摘要
With advances in genomics,transcriptomics,proteomics,and metabolomics,blooming data have been available for exploring molecular alternations in cancers.Many of these molecular alternations have been investigated as biomarkers for cancer diagnosis,prognosis,and precision therapies.It is my privilege to introduce this Special Issue of the Journal of Cancer Metastasis and Treatment,which contains four review articles and four original articles that focus on the topic of biomarker discoveries for cancer diagnosis and precision therapy.
